Comparison of phenotype and function of tumor-specific human primary T cells overexpressing IL-2, IL-7, IL-15, or IL-21
| Parameter . | ΔLNGFR . | IL-2 . | IL-7 . | IL-15 . | IL-21 . |
|---|---|---|---|---|---|
| Maintenance of T-cell numbers | |||||
| Accumulation | 0 | ++ | ++ | + | − |
| Antigen-induced proliferation | 0 | + | +++ | + | ++ |
| Bcl-2 expression | 0 | + | + | + | − |
| Long-term persistence | 0 | ND | 0 | ++ | + |
| Effector function | |||||
| CTL activity | 0 | + | 0 | ++ | + |
| Granzyme A expression | 0 | ++ | + | ++ | + |
| IFN-γ expression | 0 | + | ++ | ++ | 0 |
| TNF-α expression | 0 | + | ++ | ++ | 0 |
| IL-2 expression | 0 | +++ | + | 0 | 0 |
| Cell surface phenotype | |||||
| CD45RA−CD45RO+ expression | 0 | 0 | 0 | 0 | 0 |
| CCR7 expression | 0 | − | 0 | 0 | 0 |
| CD62L expression | 0 | − | + | − | 0 |
| CD28 expression | 0 | − | − | − | 0 |
| CD27 expression | 0 | − | − | − | 0 |
| TEM1 % | 0 | − | − | − | 0 |
| CD4+Foxp3+ % | 0 | 0 | 0 | 0 | 0 |
| Long-term persistence of TCM-like cells | 0 | ND | 0 | + | 0 |
| Avoidance of XGVHD | 0 | −− | −− | − | 0 |
| Tumor-free survival | 0 | + | ++ | + | ++ |
| Parameter . | ΔLNGFR . | IL-2 . | IL-7 . | IL-15 . | IL-21 . |
|---|---|---|---|---|---|
| Maintenance of T-cell numbers | |||||
| Accumulation | 0 | ++ | ++ | + | − |
| Antigen-induced proliferation | 0 | + | +++ | + | ++ |
| Bcl-2 expression | 0 | + | + | + | − |
| Long-term persistence | 0 | ND | 0 | ++ | + |
| Effector function | |||||
| CTL activity | 0 | + | 0 | ++ | + |
| Granzyme A expression | 0 | ++ | + | ++ | + |
| IFN-γ expression | 0 | + | ++ | ++ | 0 |
| TNF-α expression | 0 | + | ++ | ++ | 0 |
| IL-2 expression | 0 | +++ | + | 0 | 0 |
| Cell surface phenotype | |||||
| CD45RA−CD45RO+ expression | 0 | 0 | 0 | 0 | 0 |
| CCR7 expression | 0 | − | 0 | 0 | 0 |
| CD62L expression | 0 | − | + | − | 0 |
| CD28 expression | 0 | − | − | − | 0 |
| CD27 expression | 0 | − | − | − | 0 |
| TEM1 % | 0 | − | − | − | 0 |
| CD4+Foxp3+ % | 0 | 0 | 0 | 0 | 0 |
| Long-term persistence of TCM-like cells | 0 | ND | 0 | + | 0 |
| Avoidance of XGVHD | 0 | −− | −− | − | 0 |
| Tumor-free survival | 0 | + | ++ | + | ++ |
Parameters were scored using ΔLNGFR-transduced T cells as a baseline. 0 indicates equal to ΔLNGFR-transduced T cells; +, ++, +++, greater than ΔLNGFR-transduced T cells; −, −−, less than ΔLNGFR-transduced T cells; and ND, not determined.